Cara Therapeutics (CARA)
(Delayed Data from NSDQ)
$0.35 USD
0.00 (-0.80%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $0.35 0.00 (0.52%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.29 | 0.00% |
Earnings Summary
For their last quarter, Cara Therapeutics (CARA) reported earnings of -$0.56 per share, missing the Zacks Consensus Estimate of -$0.38 per share. This reflects a negative earnings surprise of 47.37%. Look out for CARA's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.29 per share, reflecting a year-over-year increase of 50%.
Earnings History
Price & Consensus
Zacks News for CARA
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
CARA: What are Zacks experts saying now?
Zacks Private Portfolio Services